| Literature DB >> 18500991 |
Frank P Elsen1, Edward J Shields, Matthew T Roe, Richard J Vandam, Jonathan D Kelty.
Abstract
BACKGROUND: Carbenoxolone (CBX), a gap junction uncoupler, alters the functioning of the pre-Bötzinger Complex (preBötC), a central pattern generating neuronal network important for the production of respiratory rhythm in mammals. Even when isolated in a 1/2 mm-thick slice of medulla oblongata from neonatal mouse the preBötC continues producing periodic bursts of action potentials, termed population bursts that are thought to be important in generating various patterns of inspiration, in vivo. Whether gap junction communication contributes to preBötC rhythmogenesis remains unresolved, largely because existing gap junction uncouplers exert numerous non-specific effects (e.g., inhibition of active transport, alteration of membrane conductances). Here, we determined whether CBX alters preBötC rhythmogenesis by altering membrane properties including input resistance (Rin), voltage-gated Na+ current (INa), and/or voltage-gated K+ current (IK), rather than by blocking gap junction communication. To do so we used a medullary slice preparation, network-level recordings, whole-cell voltage clamp, and glycyrrhizic acid (GZA; a substance used as a control for CBX, since it is similar in structure and does not block gap junctions).Entities:
Mesh:
Substances:
Year: 2008 PMID: 18500991 PMCID: PMC2413244 DOI: 10.1186/1471-2202-9-46
Source DB: PubMed Journal: BMC Neurosci ISSN: 1471-2202 Impact factor: 3.288
Figure 1Effects of CBX and GZA on population-level bursting by the preBötC. A. Sample traces of extracellular activity recorded and integrated using a 50 ms time constant in the presence of GZA or CBX. Time bar represents 20 seconds. B. Whereas CBX decreased mean burst frequency within 20 min of application (i.), slices bathed in aCSF containing 50 μM GZA continued bursting at or near baseline frequency throughout recording (Two-way RM ANOVA with treatment by time as the source of variation d.f. = 4, F = 24.025, P < 0.001). B.ii. CBX decreased the area of integrated population bursts (Two-way RM ANOVA with treatment by time as the source of variation d.f. = 4, F = 25.783, P < 0.001). B.iii., Decreased burst area with CBX treatment appears to have been due to CBX decreasing burst amplitude beginning at 30 min of treatment (Two-way RM ANOVA with treatment by time as the source of variation d.f. = 4, F = 59.14, P < 0.001), as burst duration was seemingly unaffected by CBX up to the point at which bursting ceased (B.iv). *CBX value different from aCSF control at P < 0.05. **In these figures, the 60 min data point is presented to underscore that CBX terminated preBötC bursting within 1 h of treatment.
Effects of aCSF, GZA and CBX treatment on resting membrane properties of preBötC neurons.
| aCSF | |||
| 0 min | 10 | 339.1 ± 66.4 | -60.8 ± 14.9 |
| 5 min | 10 | 362.8 ± 126.1 | -73.7 ± 14.9 |
| 10 min | 10 | 327.2 ± 63.4 | -71.2 ± 14.9 |
| 15 min | 10 | 358.1 ± 122.1 | -73.7 ± 13.5 |
| 20 min | 10 | 329.2 ± 82.4 | -82.7 ± 13.6 |
| GZA (50 μM) | |||
| 0 min | 11 | 308.2 ± 66.2 | -67.3 ± 8.4 |
| 5 min | 11 | 232.4 ± 91.9 | -110.4 ± 29.8 |
| 10 min | 11 | 212.0 ± 41.2 | -125.8 ± 25.9 |
| 15 min | 11 | 182.9 ± 79.3 | -160.8 ± 31.9 |
| 20 min | 11 | 160.0 ± 29.5 | -200.0 ± 38.7 |
| CBX (50 μM) | |||
| 0 min | 8 | 387.6 ± 48.5 | -53.9 ± 7.9 |
| 5 min | 8 | 238.7 ± 41.5 | -73.8 ± 7.3 |
| 10 min | 8 | 260.3 ± 78.1 | -116.3 ± 29.8 |
| 15 min | 7 | 237.7 ± 56.0 | -99.4 ± 14.4 |
| 20 min | 7 | 197.2 ± 40.4 | -168.9 ± 48.7 |
All values shown were obtained from neurons in the presence of CdCl2 and comparison was performed between values for respective time intervals.
1Input resistance decreased for both CBX- and GZA-treated neurons over time (Friedman's Repeated Measures ANOVA on ranks for CBX: df = 4, SS = 393977.8, MS = 98494.5, F = 2.798, P = 0.040; Friedman's Repeated Measures ANOVA on ranks for GZA: df = 4, SS = 137567.026, MS = 34391.757, F = 3.457, P = 0.023).
2Compared using Kruskal-Wallace ANOVA on Ranks (H = 44.93, d.f. = 14, P < 0.001).
Figure 2Glycyrrhizic acid and Carbenoxolone differentially affect I. A. Representative Traces from whole-cell voltage clamp experiments demonstrating the lack of change in peak INa over time in aCSF or GZA (50 μM) vs. increased peak INa in CBX (50 μM). Black trace represents control conditions and red trace represents drug effect. Vertical scale bars = 1 nA; time bar represents 1 ms. B. Current-Density vs. voltage relationships under baseline (t = 0 min) and after 20 min in the indicated treatment. Whereas GZA (50 μM) produced no consistent change in INa CBX (50 μM) increased the density of this current. C. Current density evoked during voltage steps from -60 to -30 mV. a: different from baseline (t = 0 min) at P < 0.05; b: different from aCSF at P < 0.05; c: different from GZA at P < 0.05. The numbers within each column represent sample size.
Figure 3Steady-state I. A. Representative whole cell voltage clamp traces demonstrating the lack of significant change in IK over time (20 min) in aCSF or GZA (50 μM). Horizontal scale bar = 20 ms; vertical scale bar = 1 nA. Black trace represents control conditions and red trace represents drug effect. B. Current Density vs. voltage relationships during the baseline (t = 0 min) sample and after 20 min in the indicated treatment. C. Current density evoked during voltage steps from -60 to 30 mV remained similar to baseline value during treatment with CBX or GZA. The numbers within each column represent sample size.